Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$10,551,225,859
+$2,431,897,325 QoQ
Shares Held
8,796,866
-0.3% QoQ
Ownership
0.934%
of shares outstanding
% of Portfolio
1.33%
of 13F equity value
Holder Rank
#19
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 5%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $34,817,743,578 across 17 Drug Manufacturers - General names. LLY ranks #1 (30.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
8,796,866 | $10,551,225,859 | |
| 2 | JNJ |
Johnson & Johnson
|
28,792,064 | $7,312,320,489 | |
| 3 | ABBV |
AbbVie Inc.
|
20,558,447 | $5,173,327,597 | |
| 4 | MRK |
Merck & Co., Inc.
|
26,275,718 | $3,376,429,761 | |
| 5 | AMGN |
Amgen Inc
|
6,200,994 | $2,245,503,942 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
13,828,010 | $1,747,030,778 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
24,918,384 | $1,435,797,281 | |
| 8 | PFE |
Pfizer Inc
|
59,084,573 | $1,422,756,513 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,551,225,859 | 8,796,866 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $8,119,328,534 | 8,827,564 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $9,495,343,543 | 8,835,507 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $6,789,963,705 | 8,899,035 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $7,022,996,241 | 9,009,270 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $7,576,467,210 | 9,173,478 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $7,294,025,068 | 9,448,219 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $7,303,584,817 | 8,243,882 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $7,887,233,259 | 8,711,517 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $6,873,629,014 | 8,835,453 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $5,323,425,379 | 9,132,343 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,456,314,250 | 10,158,275 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,597,391,241 | 9,802,958 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,602,633,771 | 10,490,460 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,871,094,984 | 10,581,388 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,462,817,554 | 10,709,193 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,529,430,303 | 10,885,576 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,226,741,269 | 11,267,735 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,162,070,985 | 11,447,654 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,653,777,914 | 11,485,730 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,359,131,874 | 10,278,546 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,933,774,752 | 10,351,005 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $1,818,599,106 | 10,771,139 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,628,611,955 | 11,002,648 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,830,351,204 | 11,148,442 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $1,515,131,743 | 10,922,230 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||